Synthesis and Characterization of Naringenin-Loaded Chitosan-Dextran Sulfate Nanocarrier

被引:22
作者
Muralidharan, Shruthi [1 ]
Shanmugam, Kumaran [1 ]
机构
[1] Periyar Maniammai Inst Sci & Technol, Dept Biotechnol, Thanjavur, India
关键词
Nanomedicine; Naringenin; Chitosan; Dextran sulfate; Breast cancer; IN-VITRO; DRUG-DELIVERY; NANOPARTICLES; HESPERETIN; CARRIERS; SYSTEM;
D O I
10.1007/s12247-020-09444-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose The present study focused on synthesis and characterization of polymeric nanocarrier for the hydrophobic drug, naringenin (Nar), using chitosan (CS) and dextran sulfate (DS). Method CSDS-Nar and blank CSDS nanoparticles were prepared by complex coacervation technique. The nanoparticles were characterized by scanning electron microscopy (SEM), Fourier transform-infrared spectroscopy (FTIR), X-ray diffraction (XRD), and dynamic light scattering (DLS). Cytotoxicity evaluation of blank CSDS and CSDS-Nar was performed by MTT assay after 24-h incubation. Result The nanoparticles were observed to have spherical morphology. The size and zeta potential of the CSDS-Nar were similar to 337.2 +/- 48.27 nm and - 34.4 +/- 7.45 mV, respectively. The interactions between polymer and drug were confirmed by FTIR studies. The in vitro drug release studies showed that 80% of free naringenin was released rapidly at 36 h. On the other hand, 51% naringenin was released from CSDS-Nar at 36 h. MTT assay demonstrated that at higher dose, the cell viability of MCF-7 cells was 45% and 8% after CSDS and CSDS-Nar treatment, respectively. Conclusion Hence, the empirical findings of the study suggest that CSDS nanocarrier could be utilized as a promising and ideal carrier for delivery of naringenin and similar hydrophobic drugs to cancer cells.
引用
收藏
页码:269 / 278
页数:10
相关论文
共 62 条
[1]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[2]   Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia [J].
Ahmad, Niyaz ;
Ahmad, Rizwan ;
Ahmad, Farhan Jalees ;
Ahmad, Wasim ;
Alam, Md Aftab ;
Amir, Mohd ;
Ali, Abuzer .
SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2020, 27 (01) :500-517
[3]   Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery [J].
Ahmed, Tarek A. ;
Aljaeid, Bader M. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 :483-507
[4]   Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles [J].
Anitha, A. ;
Deepagan, V. G. ;
Rani, V. V. Divya ;
Menon, Deepthy ;
Nair, S. V. ;
Jayakumar, R. .
CARBOHYDRATE POLYMERS, 2011, 84 (03) :1158-1164
[5]  
Bader AR, 2015, J VIS EXP, V95
[6]   Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date [J].
Bobo, Daniel ;
Robinson, Kye J. ;
Islam, Jiaul ;
Thurecht, Kristofer J. ;
Corrie, Simon R. .
PHARMACEUTICAL RESEARCH, 2016, 33 (10) :2373-2387
[7]  
Bodas DS, 2019, DRUG DEV IND PHARM
[8]   Penetration of mucoadhesive chitosan-dextran sulfate nanoparticles into the porcine cornea [J].
Chaiyasan, Wanachat ;
Praputbut, Sakonwun ;
Kompella, Uday B. ;
Srinivas, Sangly P. ;
Tiyaboonchai, Waree .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 149 :288-296
[9]  
Chaiyasan W, 2015, MOL VIS, V21, P1224
[10]   Mucoadhesive Chitosan-Dextran Sulfate Nanoparticles for Sustained Drug Delivery to the Ocular Surface [J].
Chaiyasan, Wanachat ;
Srinivas, Sangly P. ;
Tiyaboonchai, Waree .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (02) :200-207